Nimodipine

Product NDC: 63739-797
Requested package NDC: 63739-797-33
11-digit product format: 637390797
Labeler code: 63739
Product ID: 63739-797_bb148270-6d6f-7438-e053-2a95a90ace6e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Nimodipine
Dosage form: CAPSULE, LIQUID FILLED
Route: ORAL
Labeler: McKesson Corporation dba SKY Packaging
Application: ANDA090103
Marketing category: ANDA
Marketing start: 2015-01-01
Marketing end: 0000-00-00
Substance: NIMODIPINE
Active strength: 30 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	63739-797	63739-797-33	D	Discontinued by firm		2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090103-001	NIMODIPINE	NIMODIPINE	30MG	CAPSULE / ORAL	AB		2014-04-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A090103-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A090103-001	NIMODIPINE	30MG	CAPSULE / ORAL	AB		2014-04-07	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A090103-001	AB	1	`a50c72e98297…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63739-797-33	2020-07-22	C162847	48780-1	ab0e2407-3154-f274-e053-dbdaa90a6471	Nimodipine Capsules For Oral Use

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63739-797-33	EA - Each	63739-797	6c18d72a-e5d6-41f4-9844-6ef4d9b1117f	1	2017-03-06

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
57WA9QZ5WH	NIMODIPINE	66085-59-4	NIMODIPINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63739-797-33	63739079733	3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-797-33) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK	3 blister pack	2016-12-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Nimodipine Capsules For Oral Use	McKesson Corporation dba SKY Packaging \| Legacy Pharmaceutical Packaging, LLC	2023-12-13	HUMAN PRESCRIPTION DRUG LABEL	10